Paul Arora

Background

About Paul Arora

Paul is CEO of Inka Health (now an Onco-Innovations Ltd company) and sits on the Scientific and Clinical Advisory Board for Onco-Innovations. He is a seasoned epidemiologist and Adjunct Lecturer at the University of Toronto. He has over 15 years of experience in conducting and leading evaluations in public health and clinical epidemiology. He has a PhD in epidemiology and a strong background in biostatistics and scientific writing, which he applies to generate real-world evidence for health outcomes and policy decisions. Paul was a co-founder and CEO of Lighthouse Outcomes, a consulting firm that specialized in advanced analytics for clinical epidemiology research, which was acquired by Cytel in 2019. At Cytel, he served as a vice president and led the advanced analytics group in the real-world evidence division, where he worked on the application of cutting-edge epidemiologic methods and machine learning to health outcomes problems. He also continues to teach and mentor students and researchers in the Division of Epidemiology at the Dalla Lana School of Public Health, where he has published more than 50 peer-reviewed scientific articles and developed software for Bayesian network meta-analysis of clinical trials. He is passionate about advancing the field of epidemiology and improving health outcomes through rigorous and innovative research.